Related by context. All words. (Click for frequent words.) 75 low dose ritonavir 74 tipranavir r 74 LEXIVA r 74 ritonavir boosted 73 TPV r 72 Aptivus ® 72 tipranavir 72 receiving VICTRELIS 72 certolizumab 72 relapsed MM 72 PREZISTA ritonavir 72 dose ritonavir 72 Tipranavir 71 darunavir ritonavir 71 PEG IFN 71 interferon ribavirin 71 teriflunomide 71 LPV r 71 Pegasys peginterferon alfa 2a 71 Peg IFN 71 oxycodone CR 71 PegIFN RBV 71 APTIVUS R 71 ribavirin RBV 71 lopinavir r arm 71 APTIVUS r 71 AZT zidovudine Retrovir 71 CIMZIA TM 70 mcg BID 70 ritonavir boosted atazanavir 70 pegylated interferon alpha 70 REYATAZ R 70 lopinavir r 70 APTIVUS 70 CIMZIA ™ 70 boosted protease inhibitor 70 evaluating tivozanib 70 protease inhibitors PIs 70 plus dexamethasone 70 mg BID 70 efavirenz EFV 70 MCyR 70 placebo dexamethasone 70 fosamprenavir 69 rosuvastatin #mg 69 mycophenolate mofetil 69 alfa 2a 69 HBeAg seroconversion 69 salmeterol fluticasone 69 atazanavir sulfate 69 chlorambucil 69 nadolol 69 atazanavir Reyataz 69 8mg/kg 69 tapentadol IR 69 CANCIDAS 69 comparator arm 69 q8h 69 fluticasone salmeterol 69 atazanavir ritonavir 68 adjunctive placebo 68 Flu Cy 68 zonisamide SR 68 Betaferon R 68 HBeAg negative patients 68 Darunavir 68 plus methotrexate 68 doxorubicin docetaxel 68 daunorubicin 68 ACTEMRA TM 68 Doxil ® 68 Hycamtin ® 68 peginterferon alfa 2a 68 pegylated liposomal doxorubicin 68 IFN α 68 oblimersen 68 protease inhibitor PI 68 doripenem 68 indinavir 68 nicardipine 68 mg kg dose 68 steroid dexamethasone 68 lamivudine refractory patients 68 divalproex sodium 68 piperacillin tazobactam 68 #mg dose [002] 68 pegylated interferon alfa 68 baseline HbA1c 68 HBeAg positive 68 antiretroviral naïve 68 mg/m2 dose 68 CYPHER Stent 68 PASI scores 67 q#h 67 Natalizumab 67 oral allopurinol 67 peginterferon alfa 2b 67 sunitinib malate 67 doxorubicin cyclophosphamide 67 CR nPR 67 adalimumab Humira 67 elevated ALT 67 Elitek 67 caspofungin 67 darunavir 67 lumbar spine BMD 67 micafungin 67 docetaxel chemotherapy 67 XIENCE V PROMUS Stent 67 tipranavir ritonavir 67 desvenlafaxine succinate 67 Nebulized 67 4mg/kg 67 alpha 2a 67 IFN alfa 67 REYATAZ r arm 67 Peginterferon 67 #mg BID [003] 67 active comparator 67 Nilotinib 67 virologic breakthrough 67 cEVR 67 transaminase elevations 67 mg ustekinumab 67 unboosted 67 PREZISTA r 67 FluCAM arm 67 melphalan prednisone 67 amprenavir 67 atorvastatin #mg 67 tapentadol ER 67 MADRS score 67 oral rivaroxaban 67 peg interferon 67 inhibitor RG# 67 Acute Ischemic Stroke 67 cinacalcet 67 bendamustine 67 experienced virologic failure 67 Peginterferon Alfa 2a 67 mg tid 67 Dasatinib 67 darunavir r 67 NNRTI resistance 67 achieving PASI 67 prucalopride 67 mg qd 67 IV bolus 67 REYATAZ ® 67 oral levofloxacin 67 NRTI 66 Copegus ribavirin 66 Pemetrexed 66 FOLFOX6 66 FluCAM 66 hematologic toxicity 66 #mg dose [001] 66 salmeterol fluticasone propionate 66 pyrazinamide 66 subcutaneously administered 66 tolterodine ER 66 peginterferon alpha 2a 66 rimonabant #mg 66 mCi kg 66 unfractionated heparin UFH 66 vicriviroc 66 Pegasys ® 66 abacavir lamivudine 66 HBeAg positive patients 66 decitabine 66 mg QD 66 pomalidomide 66 NPH insulin 66 canakinumab 66 BARACLUDE ® 66 mitoxantrone plus 66 antiviral efficacy 66 PREZISTA rtv 66 Engerix B 66 comparator PI r 66 virologic response 66 Virologic 66 HBeAg + 66 pegylated interferon alfa 2a 66 genotypic resistance 66 ceftazidime 66 ritonavir Norvir 66 ALT elevations 66 azacitidine 66 enfuvirtide 66 #mg/m# [001] 66 isoproterenol 66 dose cohorts 66 Pegylated Interferon 66 NATRECOR R 66 mcg QD 66 REYATAZ ritonavir 66 HBeAg 66 ritonavir boosted lopinavir 66 achieved CCyR 66 #mg doses [002] 66 null responder HCV 66 dexamethasone Decadron 66 lymphocyte counts 66 partial remissions 66 GOUT 66 Pegylated Liposomal Doxorubicin 66 Fulvestrant 66 invasive candidiasis 66 solifenacin 66 insulin detemir 66 TMC# C# 66 ULORIC 66 mg BID dose 66 aminotransferase elevations greater 66 #mg BID [001] 66 ertapenem 66 3mg/kg 66 ribavirin USP 66 virologic failure 66 IFN beta 66 ascending dose 66 dose cytarabine 66 pegylated interferon alfa 2b 66 viral kinetics 66 highly emetogenic 66 5-FU/LV 66 lopinavir 66 CCR5 tropic HIV 66 plus prednisone prednisolone 65 clodronate 65 budesonide pMDI 65 achieved ACR# 65 DAPT 65 PEG interferon 65 somatostatin analog 65 low dose cytarabine 65 sustained virological response 65 pertuzumab 65 IOP lowering 65 azilsartan medoxomil 65 3TC lamivudine Epivir 65 nevirapine Viramune 65 mg TID 65 rFSH 65 gemcitabine Gemzar 65 refractory CLL 65 elotuzumab 65 prednisone prednisolone 65 tocilizumab 65 virological failure 65 ara C 65 oral FTY# 65 ug kg 65 LEXIVA 65 SPIRIVA ® 65 Lantus ® 65 INVIRASE 65 fluticasone furoate 65 clobazam 65 #mg QD [002] 65 budesonide formoterol 65 meropenem 65 virologic 65 evaluable subjects 65 acromegalic patients 65 diabetic neuropathic pain 65 PegIFN 65 Pharmacokinetic parameters 65 mcg doses 65 pegIFN 65 double blinded placebo 65 corifollitropin alfa 65 relapsing multiple sclerosis 65 Fludara 65 mg eq 65 corticosteroid dose 65 dexmedetomidine 65 VFEND 65 COMBIVIR 65 HCV RESPOND 2 65 cyclophosphamide doxorubicin vincristine 65 CTAP# Capsules 65 CCyR 65 virologic failures 65 microbiological eradication 65 visilizumab 65 paricalcitol 65 refractory AML 65 patients evaluable 65 bupropion SR 65 serum urate levels 65 DOXIL 65 tenofovir emtricitabine 65 irbesartan 65 tolterodine 65 neutrophil counts 65 sorafenib Nexavar ® 65 interferon alfa 65 gemcitabine carboplatin 65 fluvastatin 65 liposomal amphotericin B 65 NATRECOR ® 65 ribavirin therapy 65 statin monotherapy 65 rilpivirine 65 PSA nadir 65 lispro 65 oxycodone IR 65 paliperidone ER 65 virological response 65 posaconazole 65 Antitumor Activity 65 ARB telmisartan 65 erlotinib Tarceva ® 65 Raptiva r 65 Non inferiority 65 oral diclofenac 65 ATACAND 65 Pharmacokinetics PK 65 Lamotrigine 65 sargramostim 65 zoledronate 65 AEGR 65 Adalimumab 65 octreotide LAR 65 serum urate 65 moderate renal impairment 65 EQUETRO 65 ZOMIG Nasal Spray 65 FOLPI 65 μg dose 65 FOLFOX4 65 dose cohort 65 locoregional disease 65 liver histology 65 oral Hycamtin 65 PREZISTA r arm 65 tumor necrosis 65 mg RDEA# 65 Insulin Glargine 65 Navelbine 65 glycated hemoglobin levels 65 BENICAR 65 Naive Patients 65 celgosivir 64 naïve HCV 64 Fludarabine 64 mg Proellex 64 #mg/day [001] 64 budesonide foam 64 pimozide 64 Pegasys plus Copegus 64 ABC/3TC 64 dose escalation phase 64 lenalidomide dexamethasone 64 adalimumab 64 platelet inhibitor 64 riociguat 64 investigational protease inhibitor 64 TMP SMX 64 QTcF 64 antithrombotics 64 CR CRu 64 flutamide 64 Camptosar ® 64 colesevelam HCl 64 quetiapine XR 64 rapid virologic response 64 virologic suppression 64 Pertuzumab 64 interferon beta therapy 64 zolmitriptan 64 dose atorvastatin 64 VIAject ™ 64 BENCHMRK 64 ZACTIMA 64 gemcitabine cisplatin 64 Oral Fingolimod 64 DLTs 64 venlafaxine XR 64 serum cortisol 64 HPV-#/# 64 dosage regimens 64 boosted atazanavir 64 azacytidine 64 alpha 2b 64 #mg q8h 64 Moxifloxacin 64 COPAXONE R glatiramer acetate 64 FOLFIRI 64 oral olanzapine 64 Relapsing Multiple Sclerosis 64 Adefovir 64 MIRAPEX ER 64 INTEGRILIN R 64 rizatriptan 64 T2DM 64 CIMZIA TM certolizumab pegol 64 morphometric vertebral fractures 64 TEAEs 64 NRTIs 64 titrated glipizide 64 Aliskiren 64 dopamine partial agonist 64 EDSS scores 64 Procoralan 64 elvitegravir 64 MabCampath 64 SCIg 64 galiximab 64 Irinotecan 64 biologic DMARD 64 carboplatin paclitaxel 64 benazepril 64 docetaxel prednisone 64 TAXUS Express Stent 64 nab paclitaxel 64 tirofiban 64 Tocilizumab 64 clopidogrel Plavix 64 adefovir dipivoxil 64 alfuzosin 64 iodixanol 64 HIV RNA 64 leukemia AML 64 plus gemcitabine 64 HCV SPRINT 64 recurrent glioblastoma multiforme 64 Focalin XR 64 pegylated interferon alpha 2a 64 Treated Patients 64 receiving golimumab 64 plus OBT 64 microg 64 Relapsing Remitting Multiple Sclerosis 64 Double Blind Randomized 64 glatiramer acetate 64 haloperidol Haldol 64 bortezomib Velcade R 64 docetaxel Taxotere 64 GW# [003] 64 levetiracetam 64 receptor blocker 64 bolus dose 64 Toxicities 64 standard chemotherapy regimen 64 LymphoStat B belimumab 64 RAPAFLO 64 Partial Response 64 Epirubicin 64 adriamycin 64 RE LY ® 64 maximally tolerated dose 64 Platinol ® 64 Aloxi injection 64 antiretroviral naive 64 pegylated interferons 64 CAELYX 64 ibandronate 64 DAS# CRP 64 hA# 64 angiographic outcomes 64 Phase Ib clinical 64 imipenem 64 trastuzumab Herceptin R 64 receptor tyrosine kinase inhibitor 64 NMIBC 64 Eltrombopag 64 trials RCTs 64 VICTRELIS 64 Durezol 64 MoxDuo TM IR 64 Telmisartan 64 enalapril 64 stavudine d4T 64 basal bolus regimen 64 radiotherapy RT 64 clevidipine 64 dose melphalan 64 SPRYCEL ® 64 CHOP chemotherapy 64 gadobutrol 64 metaglidasen 64 Ritonavir 64 serum phosphorus 64 eplerenone 64 Cilostazol 64 Taxotere ® 64 treatment naive genotype 63 biochemical relapse 63 cisplatin vinorelbine 63 mitomycin 63 rFVIIa 63 myopathy rhabdomyolysis 63 coinfected patients 63 Meets Primary Endpoint 63 CRESTOR #mg 63 olmesartan 63 nilotinib 63 Viread Emtriva Sustiva 63 pharmacokinetic interactions 63 complete cytogenetic response 63 raltegravir 63 iniparib 63 refractory gout 63 Combination therapy 63 fluoxetine paroxetine 63 RLAI 63 ALT flares 63 tenofovir FTC 63 follicular lymphomas 63 LANTUS R 63 adjunctive ABILIFY 63 plus ribavirin 63 PEGINTRON TM 63 nucleotide analogue 63 AGILECT R 63 AGILECT ® 63 bacillus Calmette Guerin 63 ER CHOP 63 primary hypercholesterolemia 63 RAPTIVA 63 CrCl 63 mapatumumab 63 ddI 63 sUA 63 Mg Usa 63 receiving INTRON 63 timepoints 63 LAMICTAL 63 INCB# [003] 63 FOLFOX6 chemotherapy regimen 63 Pooled Analysis 63 INTELENCE 63 MMX mesalamine 63 etanercept Enbrel 63 FFNS 63 beclomethasone dipropionate 63 log# copies mL 63 Interferon Beta 63 dose dexamethasone 63 candesartan cilexetil 63 ARCALYST ® rilonacept 63 dapagliflozin plus 63 etravirine 63 BENICAR HCT 63 cariprazine 63 d4T stavudine Zerit 63 MYCAMINE 63 Pioglitazone 63 postoperative chemotherapy 63 neurologic progression 63 tacrolimus ointment 63 platelet reactivity 63 Erlotinib 63 MAGE A3 ASCI 63 Is Well Tolerated 63 achieved sustained virological 63 relapsed myeloma 63 peginterferon alfa 2a #KD 63 binary restenosis 63 amoxicillin clavulanate 63 rapid virological response 63 Omiganan 63 peginterferon alfa 63 Complicated Skin 63 intravenous cyclophosphamide 63 recurrent genital herpes 63 liposome injection 63 naltrexone SR 63 Elotuzumab 63 telaprevir dosed 63 NRTI resistance 63 Kivexa 63 Roche Pegasys 63 Gleevec resistant 63 Prolongs Survival 63 intracranial hemorrhage ICH 63 liposomal formulation 63 peginterferon 63 double blinded randomized 63 lamivudine monotherapy 63 Teriflunomide 63 ximelagatran 63 mometasone furoate 63 cisplatin gemcitabine 63 ACTOS ® 63 R# #mg BID 63 microgram kg 63 beta 1a 63 nucleoside naive 63 INVEGA ® 63 ARCOXIA 63 mg administered orally 63 mg hydrochlorothiazide 63 angiotensin receptor blocker ARB 63 tegaserod 63 infusional 63 SCH # 63 RESIST studies 63 aripiprazole 63 Navelbine ® 63 nelfinavir 63 zidovudine lamivudine 63 Femara letrozole 63 sustained virologic response 63 sitagliptin 63 SVR# 63 degarelix 63 Linagliptin 63 aripiprazole Abilify 63 VELCADE melphalan 63 Saquinavir 63 Mg Uk 63 aspartate aminotransferase 63 L PPDS 63 Alkeran 63 cediranib 63 interferon alfa 2b 63 aldosterone antagonist 63 hypoglycemic events 63 Traficet EN 63 undetectable HBV DNA 63 idraparinux 63 PegIntron 63 rilonacept 63 Blinatumomab 63 Lipitor #mg 63 thiazide diuretic 63 Effexor venlafaxine 63 Acute Myeloid Leukaemia AML 63 alemtuzumab treated 63 ORENCIA ® 63 Apidra ® 63 PRECiSE 63 ZOLINZA 63 mCi m 2 63 dasatinib Sprycel 63 Capecitabine 63 Dabigatran etexilate 63 Mitoxantrone 63 pimecrolimus cream 63 Index CDAI 63 INVANZ 63 combination antiretroviral therapy 63 mcg kg REBETOL 63 BEACOPP 63 5FU 63 Fluticasone 63 idarubicin 63 ziprasidone 63 mcg albinterferon alfa 2b 63 AST ALT 63 Sustiva efavirenz 63 relapsed CLL 63 Danazol 63 antidepressant efficacy 63 oral ribavirin 63 lipid lowering agents 63 null responder 63 saquinavir ritonavir 63 amisulpride 63 Kinoid 63 ABVD 63 labetalol 63 mcg kg 63 severe exacerbations 63 blinded randomized placebo controlled 63 sunitinib Sutent ® 63 COPEGUS 63 Ceplene/IL-2 63 gastrointestinal toxicities 63 MEVACOR 63 MIRAPEX 63 log# reduction 63 Sanofi Pasteur Fluzone 63 Non Responders 63 Lenalidomide 63 methotrexate monotherapy 63 doxazosin 63 hour bronchodilation 63 sorafenib Nexavar 63 #μg [002] 63 Darusentan 63 palonosetron 62 YERVOY 62 acute coronary syndromes ACS 62 randomized multicenter 62 REYATAZ r 62 pioglitazone HCl 62 NS5B polymerase 62 Vicriviroc 62 TNF antagonist 62 baseline LDH 62 recurrent GBM 62 rufinamide 62 ChronVac C R 62 lumbar spine bone 62 argatroban 62 virologically suppressed 62 vildagliptin 62 dasatinib Sprycel ® 62 retinal vein occlusion 62 FUSILEV enhances 62 nondiabetic patients 62 Antiviral Activity 62 alicaforsen enema 62 lacosamide 62 mg kg cohorts 62 favorable pharmacokinetic profile 62 pegylated liposomal doxorubicin PLD 62 Paraplatin ® 62 randomized multicenter trial 62 Chronic Hepatitis C 62 #.#/#.# mmHg [001] 62 biphasic insulin aspart 62 infliximab Remicade 62 ug dose 62 #.#/#.# mm Hg [003] 62 PRADAXA #mg 62 ALT elevation 62 pyridostigmine 62 undetectable viral 62 eosinophilic asthma 62 ISENTRESS 62 euthymic patients 62 dosing cohorts 62 ACE inhibitor ramipril 62 unresectable HCC 62 dose cyclophosphamide 62 Thal Dex 62 definite stent thrombosis 62 TAXUS Stent 62 complete cytogenetic 62 Epivir 62 Viread Emtriva 62 log# IU mL 62 clinically meaningful reductions 62 Randomized Phase 62 PRADAXA 62 treatment naïve genotype 62 phase IIb study 62 BMS # 62 clomipramine 62 seropositive patients 62 relapsed refractory multiple myeloma 62 serum calcium levels 62 Boceprevir 62 RRMS patients 62 SSRI SNRI 62 Juvenile Idiopathic Arthritis 62 K#N 62 extrapyramidal symptoms 62 ENDEAVOR II 62 venlafaxine ER 62 rituximab Rituxan 62 peginterferon alfa 2a Pegasys 62 pimecrolimus 62 ancrod 62 Xeloda ® 62 vidofludimus 62 oxaliplatin Eloxatin 62 dalteparin 62 bisoprolol 62 Ziprasidone 62 #mg BID [002] 62 Median PFS 62 proton pump inhibitor PPI 62 multicenter multinational 62 sulfasalazine 62 lamivudine 3TC 62 JAK Inhibitor 62 atazanavir 62 Neulasta ® 62 thromboembolic complications 62 mg kg BID 62 novel VDA molecule 62 inhaled fluticasone 62 NNRTIs 62 Serious adverse reactions 62 efavirenz Sustiva 62 nitazoxanide 62 Xelox 62 ALVESCO 62 immunomodulatory therapy 62 PHPT 62 -#.# log# 62 heFH 62 VARIVAX 62 Neoadjuvant 62 pramlintide metreleptin combination 62 daily subcutaneous injections 62 genotype 1a 62 thalidomide Thalomid 62 ziprasidone Geodon 62 Newly Diagnosed Multiple Myeloma 62 hepatitis C genotype 62 estramustine 62 AVONEX ® 62 Crohn Disease Activity 62 goserelin 62 Degarelix 62 quetiapine 62 methotrexate MTX 62 nonrandomized 62 Target Lesion Revascularization TLR 62 CIN2 + 62 favorable tolerability 62 crizotinib PF # 62 annualized relapse 62 GSK# [001] 62 cytogenetic responses 62 Medoxomil 62 cilengitide 62 aprepitant 62 nadroparin 62 pramlintide 62 Quetiapine 62 fatigue asthenia 62 mRCC 62 epoetin alpha 62 briakinumab 62 Folfox 62 risperidone Risperdal 62 velafermin 62 RLY# 62 heavily pretreated patients 62 detemir 62 Bosutinib 62 Aflibercept 62 Golimumab 62 primidone 62 Protease Inhibitors 62 QTc prolongation 62 p = NS 62 STRIDE PD 62 ergot derivatives 62 infusional 5-FU/LV 62 CorVue ™ 62 CLORETAZINE TM VNP#M 62 INC# 62 TO AVOID PREGNANCY WHILE 62 lupus anticoagulant 62 HER2 overexpression 62 Emselex 62 sirolimus eluting stent 62 virologic responses 62 interferon α 62 metformin monotherapy 62 TAXUS ATLAS 62 Hepatotoxicity 62 Increlex R 62 Diovan HCT 62 splenectomized patients 62 cyclophosphamide Cytoxan 62 cabazitaxel 62 gemifloxacin 62 Valsartan 62 lapatinib Tykerb 62 tigecycline 62 Ranibizumab 62 tazobactam 62 OAB symptoms 62 Fluconazole 62 #mg dose [003] 62 PEG Intron 62 mg p = 62 NNRTI resistant virus 62 lamotrigine 62 #mg/day [002] 62 inotropic 62 Hypotension 62 T2 lesions 62 VAPRISOL 62 Ophena TM 62 RoACTEMRA 62 RAPAFLO R 62 timolol 62 subcutaneous insulin 62 capecitabine Xeloda 62 Mycophenolate Mofetil 62 docetaxel Taxotere ® 62 serum IGF 62 CONCERTA 62 nucleotide analog 62 mg q8h 62 Telbivudine 62 solithromycin 62 cefuroxime 62 Fludara ® 62 adefovir 62 Isentress raltegravir 62 buprenorphine naloxone 62 Ticagrelor 62 multicenter randomized placebo controlled 62 post herpetic neuralgia PHN 62 inhaled corticosteroid ICS 62 abacavir Ziagen 62 QD dosing 62 etoposide 62 COPEGUS ribavirin 62 Platinol ® cisplatin 62 ACZ# 62 COPD exacerbation 62 paroxetine sertraline 62 MACUGEN 62 coadministration 62 S. aureus isolates 62 myoclonic seizures 62 pegfilgrastim 62 stage IIIb IV 62 trimethoprim sulfamethoxazole 62 tamoxifen Nolvadex ® 62 sotalol 62 mg dose 62 Interferon alfa 62 ciclesonide 62 Safinamide 62 beta interferons 62 nonvertebral fractures 62 angiotensin converting enzyme inhibitors 62 CYT# potent vascular disrupting 62 aspirin clopidogrel 62 neutropaenia 62 % CI #.#-#.# [007] 62 serum phosphorous 62 placebo controlled clinical 62 tenofovir Viread 62 mepolizumab 62 TAXUS Liberte Long 62 TMC# [001] 62 MoxDuo IR 62 intravitreal injections 62 NNRTI 62 mutated KRAS 61 imatinib Gleevec ® 61 dexpramipexole 61 Pegintron 61 safinamide 61 endoscopic remission 61 Vfend 61 Free Survival PFS 61 ropinirole 61 Zorbtive TM 61 oral prodrug 61 CK # plasma concentrations 61 Previously Untreated 61 mg/# h 61 % CI #.#-#.# [003] 61 mcg Albuferon 61 treatment naļve 61 HuMax EGFr 61 DEB# 61 hypophosphatemia 61 HCTZ 61 lumiliximab 61 Epratuzumab 61 venlafaxine Effexor 61 opioid naïve 61 PEGylated interferon beta 1a 61 Tekturna HCT 61 Neulasta R 61 sorafenib Nexavar R 61 Metoprolol 61 TURBT 61 administered subcutaneously 61 Noxafil 61 Intravitreal 61 liposomal doxorubicin 61 MULTAQ 61 PROMACTA 61 TREDAPTIVE 61 infliximab monotherapy 61 efavirenz emtricitabine 61 maximal dose 61 terfenadine 61 metastatic CRC 61 basiliximab 61 Sitagliptin 61 HIV coinfected 61 interferon alfa 2a 61 relapsed ovarian cancer 61 Amrubicin 61 dose dependently 61 pharmacokinetics PK 61 nonnucleoside reverse transcriptase inhibitors 61 FSAD 61 clinically meaningful improvement 61 â ‰ ¥ 61 tolvaptan 61 clozapine Clozaril 61 reteplase 61 #mg/#mg 61 nortriptyline 61 ALGRX 61 #mg ritonavir 61 ivabradine 61 Drug eluting stent